Mitchell Mcleod Pugh & Williams Inc Gilead Sciences, Inc. Transaction History

Mitchell Mcleod Pugh & Williams Inc

$476 Million
Q3 2024

A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 9,533 shares of GILD stock, worth $880,944. This represents 0.17% of its overall portfolio holdings.

Number of Shares

9,533

Previous 9,533 -0.0%

Holding current value

$880,944

Previous $654,000 22.17%

% of portfolio

0.17%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$71.58 - $87.29 $12,168 - $14,839	-170 Reduced 1.75%	9,533 $698,000
Q4 2023 Feb 05, 2024	SELL	$73.27 - $83.09 $1,172 - $1,329	-16 Reduced 0.16%	9,703 $786,000
Q3 2023 Oct 20, 2023	BUY	$73.94 - $80.67 $1,256 - $1,371	17 Added 0.18%	9,719 $728,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $8,581 - $9,776	-111 Reduced 1.13%	9,702 $804,000
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $4,611 - $6,620	-74 Reduced 0.75%	9,813 $842,000
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $76,508 - $87,392	-1,285 Reduced 11.5%	9,887 $610,000
Q2 2022 Nov 18, 2022	BUY	$57.72 - $65.01 $74,170 - $83,537	1,285 Added 13.0%	11,172 $691,000
Q2 2022 Jul 19, 2022	SELL	$57.72 - $65.01 $16,507 - $18,592	-286 Reduced 2.5%	11,172 $691,000
Q1 2022 Apr 26, 2022	SELL	$57.92 - $72.58 $29,481 - $36,943	-509 Reduced 4.25%	11,458 $681,000
Q4 2021 Feb 02, 2022	SELL	$64.88 - $73.64 $20,437 - $23,196	-315 Reduced 2.56%	11,967 $869,000
Q2 2021 Nov 08, 2021	BUY	$63.47 - $69.35 $5,458 - $5,964	86 Added 0.71%	12,282 $846,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $5,458 - $5,964	-86 Reduced 0.7%	12,196 $840,000
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $10,320 - $11,775	172 Added 1.42%	12,282 $794,000
Q3 2020 Oct 27, 2020	BUY	$62.1 - $78.08 $28,938 - $36,385	466 Added 4.0%	12,110 $765,000
Q2 2020 Jul 17, 2020	BUY	$72.34 - $84.0 $72,846 - $84,588	1,007 Added 9.47%	11,644 $896,000
Q1 2020 Apr 08, 2020	BUY	$62.63 - $80.22 $42,588 - $54,549	680 Added 6.83%	10,637 $795,000
Q4 2019 Jan 08, 2020	SELL	$61.62 - $67.78 $1,478 - $1,626	-24 Reduced 0.24%	9,957 $647,000
Q3 2019 Oct 08, 2019	SELL	$62.51 - $69.0 $29,067 - $32,085	-465 Reduced 4.45%	9,981 $633,000
Q1 2019 Apr 11, 2019	BUY	$62.53 - $70.05 $26,887 - $30,121	430 Added 4.29%	10,446 $679,000
Q2 2018 Jul 13, 2018	SELL	$64.88 - $75.68 $19,464 - $22,704	-300 Reduced 2.91%	10,016 $710,000
Q1 2018 Apr 16, 2018	SELL	$72.84 - $88.8 $72,840 - $88,800	-1,000 Reduced 8.84%	10,316 $778,000
Q4 2017 Jan 12, 2018	SELL	$71.15 - $83.52 $26,325 - $30,902	-370 Reduced 3.17%	11,316 $811,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $842,677 - $998,802	11,686	11,686 $947,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.

Account

Mitchell Mcleod Pugh & Williams Inc Gilead Sciences, Inc. Transaction History